病态肥胖孕妇的母体血流动力学受损:病例对照研究
这项前瞻性病例对照研究纳入23例病态肥胖孕妇(BMI≥40 kg/m²)和327例对照(BMI 20-29.9 kg/m²),用USCOM-1A®设备评估血流动力学。肥胖组平均动脉压、心率更高,经体表面积校正后心脏指数和每搏指数显著降低、体循环血管阻力指数显著升高。作者认为肥胖孕妇心脏功能显著改变,降低的心脏指数可能解释其子痫前期易感性,需进一步研究。
要点
- 病态肥胖孕妇经体表面积校正后心脏指数和每搏指数显著低于对照,体循环血管阻力指数显著更高。
- 肥胖组平均动脉压和心率高于对照,但每搏量、心输出量和体循环血管阻力未校正时无差异。
- 作者认为血流动力学参数应按体表面积校正比较,心脏指数降低可能解释子痫前期易感性。
核心结论
- 研究结果提示病态肥胖孕妇的心脏功能显著改变。
- 作者认为血流动力学参数必须按体表面积校正才能进行个体间适当比较,正如儿科心脏病学的标准做法。
- 病态肥胖孕妇心脏指数降低这一新发现可能解释该人群对子痫前期和其他不良结局的易感性,需进一步研究。
研究设计与样本
- 前瞻性病例对照研究,纳入病态肥胖孕妇(BMI≥40 kg/m²)与对照(BMI 20-29.9 kg/m²),对照按母亲年龄和孕龄匹配。
- BMI基于招募时(与血流动力学评估同一天)的母亲身高和体重计算,纳入孕中期或孕晚期孕妇,任何时候发现高血压者排除。
- 使用USCOM-1A®设备评估心率、每搏量、心输出量和体循环血管阻力,并按体表面积校正为每搏指数、心脏指数和体循环血管阻力指数。
- 共23例病态肥胖孕妇和327例对照纳入分析,采用Mann-Whitney U检验比较两组血流动力学变量的中位数。
主要发现
- 肥胖组与对照组招募时母亲年龄(P=0.506)和孕龄(P=0.693)无差异。
- 肥胖组平均动脉压在妊娠登记时(90 vs 80 mmHg,P<0.001)和研究招募时(91 vs 85 mmHg,P<0.001)均高于对照组。
- 肥胖组心率更高(P=0.003),但每搏量(P=0.271)、心输出量(P=0.238)和体循环血管阻力(P=0.635)无差异。
- 按体表面积校正后,肥胖组每搏指数(34 vs 45 mL/m²,P<0.001)和心脏指数(2.96 vs 3.64 L/min/m²,P<0.001)显著低于对照组,体循环血管阻力指数显著更高(2354 vs 1840 dynes×s/cm⁵,P<0.001)。
临床怎么用
- 作者认为为使个体间比较适当,血流动力学参数应按体表面积校正,正如儿科心脏病学的标准做法。
- 作者认为病态肥胖孕妇心脏指数降低可能解释该人群对子痫前期和其他不良结局的易感性,需进一步研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Maternal obesity is associated with significant pregnancy complications and is a risk factor for the development of hypertensive disorders of pregnancy as well as other adverse outcomes. There are few data regarding the hemodynamic aberrations observed in maternal obesity. The aim of this study was to investigate maternal hemodynamics in morbidly obese women. METHODS: This was a prospective, case-control study of morbidly obese women (body mass index (BMI) ≥ 40 kg/m2 ) and controls (BMI 20-29.9 kg/m2 ). The control population was matched for maternal age and gestational age. BMI was calculated based on maternal height and weight at the time of recruitment to the study, which occurred on the same day as the hemodynamic assessment. Pregnant women in the second or third trimester of pregnancy were included. Women who were found to be hypertensive at any time were excluded from the study. A USCOM-1A® device was used to assess hemodynamic parameters (heart rate, stroke volume (SV), cardiac output and systemic vascular resistance (SVR)). The parameters were corrected for body surface area (BSA) to provide the SV index (SVI), cardiac index (CI) and SVR index (SVRI). Mann-Whitney U-test was used to compare the medians of the hemodynamic variables between the two groups. RESULTS: In total, 23 morbidly obese women and 327 controls were included in the analysis. There was no difference in maternal (P = 0.506) or gestational (P = 0.693) age at recruitment between the groups. Mean arterial pressure was higher both at pregnancy booking (90 vs 80 mmHg, P < 0.001) and study recruitment (91 vs 85 mmHg, P < 0.001) in the obese group compared with the controls. Heart rate was higher in the obese group (P = 0.003), but there was no difference in SV (P = 0.271), cardiac output (P = 0.238) or SVR (P = 0.635). Following correction of these parameters for BSA, compared with the control group, SVI (34 vs 45 mL/m2 , P < 0.001) and CI (2.96 vs 3.64 L/min/m2 , P < 0.001) were significantly reduced in the obese group, whereas SVRI was significantly higher (2354 vs 1840 dynes × s/cm5 , P < 0.001). CONCLUSIONS: The findings of our study suggest that cardiac function is significantly altered in morbidly obese pregnant women. In order to make appropriate comparisons between individuals, it is imperative that hemodynamic parameters are indexed for BSA, as is standard practice in pediatric cardiology. The novel finding of reduced CI in morbidly obese pregnant women may explain the predisposition to pre-eclampsia and other adverse outcomes in this population and warrants further investigation. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Vinayagam D, Gutierrez J, Binder J, et al. Impaired maternal hemodynamics in morbidly obese women: a case-control study. Ultrasound Obstet Gynecol. 2017. PMID: 28150433. doi:10.1002/uog.17428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。